{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:24:29Z","timestamp":1792110269077,"version":"4.4.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Fibrovascular contraction and tractional retinal detachment (TRD) are recognized complications associated with the use of anti\u2013vascular endothelial growth factor agents in vasoproliferative vitreoretinopathies. The authors characterize TRDs that developed after intravitreal bevacizumab or ranibizumab therapy for vascularly active retinopathy of prematurity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This is an international, multicenter, interventional, retrospective, case series. Thirty-five eyes from 23 infants were included. Inclusion required anti\u2013vascular endothelial growth factor treatment of Type 1 retinopathy of prematurity with progression to TRD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Mean gestational age was 26 \u00b1 2 weeks, and mean birth weight was 873 \u00b1 341 g. Mean postmenstrual age on the day of injection was 35 \u00b1 2 weeks. Retinal detachment was noted a mean of 70 days (median, 34; range, 4\u2013335) after injection. Eleven percent detached within 1 week, 23% within 2 weeks, and 49% within 4 weeks. The highest stage of retinopathy of prematurity noted was 4A in 29%, 4B in 37%, and 5 in 34% of eyes. Time to RD negatively correlated with postmenstrual age at the time of injection (\n                      <jats:italic toggle=\"yes\">Rho<\/jats:italic>\n                      = \u22120.54;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). Three TRD configurations were observed: 1) conventional peripheral elevated ridge or volcano-shaped Stage 5 detachment, 2) midperipheral detachment with tight circumferential vectors, and 3) very posterior detachment with prepapillary contraction. Full or partial reattachment was achieved with surgical intervention in 86% of eyes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Progressive atypical TRD may occur after anti\u2013vascular endothelial growth factor injections for retinopathy of prematurity. The configuration of the detachment varies with the extent of primary retinal vascularization present at the time of treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/iae.0000000000001685","type":"journal-article","created":{"date-parts":[[2017,5,4]],"date-time":"2017-05-04T13:46:37Z","timestamp":1493905597000},"page":"1079-1083","source":"Crossref","is-referenced-by-count":88,"title":["PROGRESSIVE RETINAL DETACHMENT IN INFANTS WITH RETINOPATHY OF PREMATURITY TREATED WITH INTRAVITREAL BEVACIZUMAB OR RANIBIZUMAB"],"prefix":"10.1097","volume":"38","author":[{"given":"Yoshihiro","family":"Yonekawa","sequence":"first","affiliation":[{"name":"Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts;"},{"name":"Pediatric Retina Surgery Service, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Chang Gung Memorial Hospital and Chang Gung University, College of Medicine, Taoyuan, Taiwan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina E.","family":"Nitulescu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, National Institute for Mother and Child Health Alessandrescu-Rusescu, Bucharest, Romania;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.V. Paul","family":"Chan","sequence":"additional","affiliation":[{"name":"Retina Service, Department of Ophthalmology, Illinois Eye and Ear Infirmary, University of Illinois College of Medicine, Chicago, Illinois;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aristomenis","family":"Thanos","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants, Royal Oak, Michigan;"},{"name":"Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Rochester, Michigan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Thomas","sequence":"additional","affiliation":[{"name":"Florida Retina Institute, Jacksonville, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozho","family":"Todorich","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants, Royal Oak, Michigan;"},{"name":"Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Rochester, Michigan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Drenser","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants, Royal Oak, Michigan;"},{"name":"Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Rochester, Michigan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Trese","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants, Royal Oak, Michigan;"},{"name":"Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Rochester, Michigan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Capone","sequence":"additional","affiliation":[{"name":"Associated Retinal Consultants, Royal Oak, Michigan;"},{"name":"Department of Ophthalmology, Oakland University William Beaumont School of Medicine, Rochester, Michigan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230816","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.ophtha.2009.04.026","article-title":"Simultaneous analyses of vitreous levels of 27 cytokines in eyes with retinopathy of prematurity","volume":"116","author":"Sato","year":"2009","journal-title":"Ophthalmology"},{"key":"R2-20230816","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1167\/iovs.08-2510","article-title":"Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab","volume":"50","author":"Funk","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R3-20230816","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2007.127142","article-title":"Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy","volume":"92","author":"Arevalo","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"R4-20230816","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00417-008-0786-7","article-title":"Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity","volume":"246","author":"Honda","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R5-20230816","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jaapos.2010.05.011","article-title":"Delayed-onset retinal detachment after an intravitreal injection of ranibizumab for zone 1 plus retinopathy of prematurity","volume":"14","author":"Jang","year":"2010","journal-title":"J AAPOS"},{"key":"R6-20230816","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.3928\/01913913-20101217-06","article-title":"Retinal detachment despite aggressive management of aggressive posterior retinopathy of prematurity","volume":"47","author":"Suk","year":"2010","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"R7-20230816","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/archophthalmol.2011.1802","article-title":"Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity","volume":"130","author":"Patel","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"R8-20230816","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","article-title":"Reactivation of retinopathy of prematurity after bevacizumab injection","volume":"130","author":"Hu","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"R9-20230816","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/eye.2012.111","article-title":"Delayed onset atypical vitreoretinal traction band formation after an intravitreal injection of bevacizumab in stage 3 retinopathy of prematurity","volume":"26","author":"Lee","year":"2012","journal-title":"Eye (Lond)"},{"key":"R10-20230816","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3928\/23258160-20160324-08","article-title":"Hybrid 25- and 27-gauge vitrectomy for complex vitreoretinal surgery","volume":"47","author":"Yonekawa","year":"2016","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R11-20230816","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1167\/iovs.09-4065","article-title":"Alterations in the intraocular cytokine milieu after intravitreal bevacizumab","volume":"51","author":"Forooghian","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R12-20230816","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1172\/JCI114065","article-title":"Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye","volume":"83","author":"Connor","year":"1989","journal-title":"J Clin Invest"},{"key":"R13-20230816","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000223949","article-title":"Anti-angiogenic therapy in the management of retinopathy of prematurity","volume":"44","author":"Drenser","year":"2009","journal-title":"Dev Ophthalmol"},{"key":"R14-20230816","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0161-6420(91)32343-1","article-title":"Visual acuity in infants after vitrectomy for severe retinopathy of prematurity","volume":"98","author":"Quinn","year":"1991","journal-title":"Ophthalmology"},{"key":"R15-20230816","doi-asserted-by":"crossref","first-page":"18751","DOI":"10.1073\/pnas.0905010106","article-title":"An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris","volume":"106","author":"Saint-Geniez","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-20230816","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1167\/iovs.05-1229","article-title":"VEGF expression and receptor activation in the choroid during development and in the adult","volume":"47","author":"Saint-Geniez","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R17-20230816","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00417-009-1054-1","article-title":"Changes in choriocapillaris fenestration of rat eyes after intravitreal bevacizumab injection","volume":"247","author":"Shimomura","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R18-20230816","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20072041","article-title":"VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma","volume":"205","author":"Maharaj","year":"2008","journal-title":"J Exp Med"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006982-201806000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T20:27:12Z","timestamp":1692217632000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006982-201806000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000001685","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]}}}